A clinical trial to study the efficasy of an ayurvedic formulation in infantile colic

An Open Label, Single Arm Clinical Trial on Effectiveness and Safety of Caspa - A Herbal Carminative, Anti-spasmodic Drops in Infantile Abdominal Colic in Children between 2 to 24 months of age - IAC-VACD

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/03/008237

Enrollment

100

Registered

2017-03-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Infantile colic

Interventions

Intervention1: Caspa Herbal Carminative And Anti-Spasmodic Drops: Infants between 2 to 12 months: 10 drops (approx. 0.5 mL), 4 times a day, 15 minutes before feed, orally Young children between 13 mon

Eligibility

Inclusion criteria

Inclusion criteria: Infants with Infantile colic and whose parents willing to give consent to participate in the study

Exclusion criteria

Exclusion criteria: Infants and young children suffering from acute illness

Design outcomes

Primary

Measure	Time frame
1 Reduction in colic 2 Improvement in Appetite 3 Improvement in Digestion 4 Reduction in flatulance 5 Bowel activity 6 Improvement in General health 7 Weight gain Timepoint: 6 weeks	—

Secondary

Measure	Time frame
Assessment of drug safetyTimepoint: 6 weeks	—

Countries

India

Contacts

Public ContactDr Vijayalaxmi Mallannavar

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital

rao.shaila@gmail.com9448816433

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026